Table 4. Clinical characteristics of patients with or without recurrent pneumonitis.
p = .08.
Disease control cases with no progression of disease.
Abbreviations: Ipi‐nivo, ipilimumab and nivolumab combination; irAE, immune‐related adverse event; n/a, not applicable; PD‐1, programmed cell death 1.